RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release

Virology

Volumn 462-463, Issue 1, 2014, Pages 126-134

  López, Claudia S ^a   Sloan, Rachel ^a   Cylinder, Isabel ^a   Kozak, Susan L ^a   Kabat, David ^a   Barklis, Eric ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Env; Gag; HIV 1; RNA export; RRE

Indexed keywords

GAG PROTEIN; MESSENGER RNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REV RESPONSIVE ELEMENT; RNA STRUCTURE; RNA TRANSPORT; VIRUS PARTICLE; VIRUS RELEASE;

ENV; GAG; HIV-1; RNA EXPORT; RRE;

ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENES, ENV; HIV-1; RNA, VIRAL; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84902995327     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.05.019     Document Type: Article

References (57)

1. Adachi A., Gendelman H., Koenig S., Folks T., Willey R., Rabson A., Martin M. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 1986, 59:284-291.
2. Alting-Mees M., Short J. pBluescriptII: gene mapping vectors. Nucleic Acids Res. 1989, 17:9494.
3. Boge M., Wyss S., Bonifacino J., Thali M. A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J. Biol. Chem. 1998, 273:15773-15778.
4. Bolivar F., Rodriguez R., Greene P., Betlach M., Heyneker H., Boyer H., Crosa J., Falkow S. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 1977, 2:95-113.
5. Chakrabarti B., Kong W.P., Wu B.Y., Yang Z.Y., Friborg J., Ling X., King S., Montefiori D., Nabel G. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J. Virol. 2002, 76:5357-5368.
6. Chan W., Chen S. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein. Virology 2006, 348:418-429.
7. Checkley M., Luttge B., Freed E. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J. Mol. Biol. 2011, 410:582-608.
8. Connor R., Chen B., Choe S., Landau N. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206:935-944.
9. Courageot J., Fenouillet E., Bastiani P., Miquelis R. Intracellular degradation of the HIV-1 envelope glycoprotein. Evidence for, and some characteristics of, an endoplasmic reticulum degradation pathway. Eur. J. Biochem. 1999, 260:482-489.
10. Cullen B. Human immunodeficiency virus: nuclear RNA export unwound. Nature 2005, 433:26-27.
11. De Wet J., Wood K., Helinski D., Deluca M. Cloning firefly luciferase. Methods Enzymol. 1986, 133:3-14.
12. DuBridge R., Tang P., Hsia H., Leong P., Miller J., Calos M. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 1987, 7:379-387.
13. Egan M., Carruth L., Rowell J., Yu X., Siliciano R. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 1996, 70:6547-6556.
14. Elinav H., Wu Y., Coskun A., Hryckiewicz K., Kemler I., Hu Y., Rogers H., Hao B., Mamoun C., Poeschla E., Sutton R. Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells. J. Virol. 2012, 86:12053-12068.
15. Fischer U., Meyer S., Teufel M., Heckel C., Lührmann R., Rautmann G. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 1994, 13:4105-4112.
16. Fischer U., Huber J., Boelens W., Mattaj I., Lührmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995, 82:475-483.
17. Fischer U., Pollard V., Lührmann R., Teufel M., Michael M., Dreyfuss G., Malim M. Rev-mediated nuclear export of RNA is dominant over nuclear retention and is coupled to the Ran-GTPase cycle. Nucleic Acids Res. 1999, 27:4128-4134.
18. Freed E., Martin M. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 1995, 69:1984-1989.
19. Freed E., Martin M. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 1995, 270:23883-23886.
20. Freed E., Martin M. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 1996, 70:341-351.
21. Gabuzda D., Lever A., Terwilliger E., Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 1992, 66:3306-3315.
22. Groom H., Anderson E., Dangerfield J., Lever A. Rev regulates translation of human immunodeficiency virus type 1 RNAs. J. Gen. Virol. 2009, 90:1141-1147.
23. Henderson B., Percipalle P. Interactions between HIV Rev and nuclear import and export factors: the Rev nuclear localisation signal mediates specific binding to human importin-beta. J. Mol. Biol. 1997, 274:693-707.
24. Jin J., Sturgeon T., Weisz O., Mothes W., Montelaro R. HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking. PLoS One 2009, 4(8):e6551.
25. Kotsopoulou E., Kim V., Kingsman A., Kingsman S., Mitrophanous K. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 2000, 74:4839-4852.
26. Lai L.T., Lee P., Zhang L.F. Immunofluorescence protects RNA signals in simultaneous RNA-DNA FISH. Exp. Cell Res. 2013, 319:46-55.
27. Li Y., Hui H., Burgess C., Price R., Sharp P., Hahn B., Shaw G. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 1992, 66:6587-6600.
28. Lodge R., Gottlinger H., Gabuzda D., Cohen E., Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 1994, 68:4857-4861.
29. Lodge R., Lalonde J., Lemay G., Cohen E. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J. 1997, 16:695-705.
30. López C., Tsagli S., Sloan R., Eccles J., Barklis E. Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein. Virology 2013, 447:95-103.
31. Mammano F., Kondo E., Sodroski J., Bukovsky A., Göttlinger H. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 1995, 69:3824-3830.
32. Mautino M., Morgan R. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense. Gene Ther. 2002, 9:421-431.
33. Murakami T., Freed E. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc. Natl. Acad. Sci. USA 2000, 97:343-348.
34. Murakami T., Freed E. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 2000, 74:3548-3554.
35. Muranyi W., Malkusch S., Muller B., Heilemann M., Krausslich H.G. Super-resolution microscopy reveals specific recruitment of HIV-1 Envelope proteins to viral assembly sites dependent on Envelope C-terminal tail. PLoS Pathog. 2013, 9(2):e1003198.
36. Noviello C., López C., Kukull B., McNett H., Still A., Eccles J., Sloan R., Barklis E. Second-site compensatory mutations of HIV-1 capsid mutations. J. Virol. 2011, 85:4730-4738.
37. Page K., Landau N., Littman D. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 1990, 64:5270-5276.
38. Pasquinelli A., Ernst R., Lund E., Grimm C., Zapp M., Rekosh D., Hammarskjöld M., Dahlberg J. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 1997, 16:7500-7510.
39. Perales C., Carrasco L., González M. Regulation of HIV-1 env mRNA translation by Rev protein. Biochim. Biophys. Acta 2005, 1743:169-175.
40. Santos da Silva E., Mulinge M., Bercoff D. The frantic play of the concealed HIV envelope cytoplasmic tail. Retrovirology 2013, 10:54.
41. Scholz I., Arvidson B., Huseby D., Barklis E. Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain. J. Virol. 2005, 79:1470-1479.
42. Scholz I., Still A., Dhenub T., Coday K., Webb M., Barklis E. Analysis of human immunodeficiency virus matrix domain replacements. Virology 2008, 371:322-335.
43. Sherer N., Swanson C., Papaioannou S., Malim M. Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells. J. Virol. 2009, 83:8525-8535.
44. Sherer N., Swanson C., Hué S., Roberts R., Bergeron J., Malim M. Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication. PLoS Pathog. 2011, 7(11):e1002395.
45. Sodroski J., Goh W., Rosen C., Campbell K., Haseltine W. Role of the HTLVIII/LAV envelope in syncytium formation and cytopathicity. Nature 1986, 322:470-474.
46. Sullivan N., Sun Y., Hofmann W., Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 1995, 69:4413-4422.
47. Swanson C., Puffer B., Ahmad K., Doms R., Malim M. Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J. 2004, 23:2632-2640.
48. Swanson C., Sherer N., Malim M. SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. J. Virol. 2010, 84:6748-6759.
49. Wang C.T., Zhang Y., McDermott J., Barklis E. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 1993, 67:7067-7076.
50. Ward A., Rekosh D., Hammarskjold M. Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene. J. Virol. 2009, 83:940-952.
51. Welman M., Lemay G., Cohen E. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex. Virus Res. 2007, 124:103-112.
52. Wodrich H., Schambach A., Kräusslich H.G. Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res. 2000, 28:901-910.
53. Wong R., Balachandran A., Haaland M., Stoilov P., Cochrane A. Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function. Nucleic Acids Res. 2013, 41:9471-9483.
54. Wyma D., Kotov A., Aiken C. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J. Virol. 2000, 74:9381-9387.
55. Yi R., Bogerd H., Cullen B. Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs. J. Virol. 2002, 76:2036-2042.
56. Yu X., Yuan X., McLane M., Lee T., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 1993, 67:213-221.
57. Zufferey R., Nagy D., Mandel R., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15:871-875.